For
p
atients
For
r
esearch sites
Find a trial
Researchers
Sponsors
Patients
Company
Log in
Get started
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)